Longitudinal clinical proteomics reveals pneumonia type–specific protein biomarkers and autoantibodies
Open Access
- 23 April 2026
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (11)
Abstract
Community-acquired pneumonia is a major cause of morbidity and mortality globally. Specific molecular endotypes are currently not well defined, and different viral or bacterial pathogens may trigger specific host responses and pathogenic mechanisms. We performed longitudinal proteomic profiling of bronchoalveolar lavage fluid and plasma from bacterial, influenza, and SARS-CoV-2–driven pneumonia. Our analysis revealed highly pneumonia type–specific proteomic signatures, including COVID-19–specific antibodies locally produced in the lung. These antibodies showed biased immunoglobulin V–domain usage, linked to a CD69 / CD83 plasma cell state associated with disease severity and degree of autoimmunity. Using mass spectrometry–driven autoantibody profiling in 2 independent COVID-19 cohorts, we identified 177 putative autoantibodies targeting extracellular matrix, nuclear, and immune-related proteins. Of note, temporal changes in autoantibody profiles correlated with clinical markers of inflammation, organ dysfunction, and duration of hospitalization. These findings highlight the autoimmune aspects of COVID-19 and provide potential biomarkers and therapeutic targets to help improve patient outcomes.Keywords
Funding Information
- Veterans Administration (I01CX001777)
- FDA (75F40122C00134)
- CoViPa - Virological and immunological determinants of COVID-19 pathogenesis (NA)
- National Institutes of Health (U19AI135964,P01AG049665,P01HL154998,P01HL169188,U19AI181102,R01HL153312,R01ES034350,U54AG079754,R01HL147575,R01HL147290,R21AG075423,R01HL158139,R01HL149883,R01HL153122,R01AI158530,U01TR003528,R01HL149883-01)
This publication has 83 references indexed in Scilit:
- Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptorsAutoimmunity Reviews, 2023
- The majority of severe COVID-19 patients develop anti-cardiac autoantibodiesGeroScience, 2022
- COVID‐19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severityJournal of Medical Virology, 2022
- Dynamic spectrum of ectopic lymphoid B cell activation and hypermutation in the RA synovium characterized by NR4A nuclear receptor expressionCell Reports, 2022
- Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndromeSeminars in Immunopathology, 2022
- Multiple early factors anticipate post-acute COVID-19 sequelaeCell, 2022
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyCell, 2020
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19Cell, 2020
- Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomesJournal of Medical Virology, 2020
- Supporting the multi-criteria decision aiding process: R and the MCDA packageEURO Journal on Decision Processes, 2017